Determining the true risk of CVD by measuring all potentially atherogenic lipoproteins
Apo B shows atherogenic signs and is therefore useful for the evaluation of coronary risk.
The test is undertaken:
- When the patient has a personal or family history of heart disease and/or high concentrations of lipids in the blood
- To determine the patient’s risk of developing CVD
- To help monitor treatment for hyperlipidaemia
- To help diagnose APO B deficiency
Apolipoproteins interact with a series of enzymes and tissue receptors and are therefore responsible for further metabolism of the micelle. The B apolipoproteins are the main form of protein found in the low density lipoproteins (LDL). Apo B is the main cholesterol carrying protein in the blood and is the ligand concerned with the uptake of cholesterol into the cells by the LDL – receptor pathway.
Key Features of Randox Apolipoprotein B
- Wide measuring range – With a measuring range of 11.2-184 mg/dl, it will comfortably detect levels outside of the healthy range of 63-114 mg/dl
- Excellent stability – Stable to expiry when stored at 2-8°C
- Liquid ready-to-use reagents – The Randox Apolipoprotein B reagent comes in a liquid format which is more convenient, and can also help reduce the risk of errors occurring
- Immunoturbidimetric method
RIQAS EQA Scheme
- Lipid Programme
- Clinical Chemistry Controls
- Lipid Controls
- Lipid Calibrators
|LP2117||R1 4 x 50ml (c)||R2 4 x 9ml|
|LP2990||R1 4 x 60ml (c)||R2 4 x 15ml|
|LP3839||R1 4 x 20ml||R2 4 x 6ml|
|LP8008||R1 2 x 10ml||R2 2 x 4ml|
Applications are available for a large range of clinical chemistry analysers. Contact us for more information.